A novel BIM deletion polymorphism: implications and lessons for cancer targeted therapies.
Cancer & Stem Cell Biology Signature Research Programme, Duke-NUS Graduate Medical School.
Sheila
S
Soh
S Tiong
ST
Ong
D000818:Animals; D051017:Apoptosis Regulatory Proteins / Q000235:genetics*; D000072224:Bcl-2-Like Protein 11; D019008:Drug Resistance, Neoplasm; D006801:Humans; D008565:Membrane Proteins / Q000235:genetics*; D009369:Neoplasms / Q000235:genetics / Q000628:therapy*; D011110:Polymorphism, Genetic / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D017384:Sequence Deletion / Q000235:genetics*
D051017:Apoptosis Regulatory Proteins; C000606775:BCL2L11 protein, human; D000072224:Bcl-2-Like Protein 11; D008565:Membrane Proteins; D011518:Proto-Oncogene Proteins